Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 8/20 | 0.54 |
| ▸ | CNR1 | P21554 | 8/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23249707 | 1.00 | CNR2 (0.54) | CNR2CNR1MEN1KMT2A | |
| SCHEMBL29874512 | 1.00 | CNR2 (0.54) | CNR2CNR1MEN1KMT2A | |
| SCHEMBL22946426 | 1.00 | CNR2 (0.54) | CNR2CNR1MEN1KMT2A | |
| SCHEMBL23765170 | 0.86 | CNR1 (0.73) | CNR2CNR1 | |
| SCHEMBL25268322 | 0.84 | CNR2 (0.61) | CNR2CNR1 | |
| SCHEMBL22946285 | 0.84 | CNR2 (0.61) | CNR2CNR1 | |
| SCHEMBL23765260 | 0.84 | CNR2 (0.61) | CNR2CNR1 | |
| SCHEMBL23765234 | 0.84 | CNR1 (0.70) | CNR2CNR1 | |
| SCHEMBL23765328 | 0.81 | CNR2 (0.59) | CNR2CNR1 | |
| SCHEMBL23765210 | 0.80 | CNR1 (0.64) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522576-B2 | Polymorphs of D9-THC naphthoylester | PURISYS LLC (US) | 2026-01-13 | — | — | US | disclosed |
| US-20240109857-A1 | POLYMORPHS OF D9-THC NAPHTHOYLESTER | NORAMCO, LLC | 2024-04-04 | — | — | US | disclosed |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| WO-2021163023-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. (US) | 2021-08-19 | — | — | WO | disclosed |
| US-20210251947-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. | 2021-08-19 | — | — | US | disclosed |
| WO-2021076633-A1 | POLYMORPHS OF D9-THC NAPHTHOYLESTER | PURISYS LLC (US) | 2021-04-22 | — | — | WO | disclosed |
| WO-2021076633-A1 | POLYMORPHS OF D9-THC NAPHTHOYLESTER | PURISYS LLC (US) | 2021-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109857-A1 | POLYMORPHS OF D9-THC NAPHTHOYLESTER | DHCR24, CNR1, CNR2 | CNR2 3/4885CNR1 2/4885MEN1 3350/4885 |
| US-20210251947-A1 | STABLE FORMULATIONS OF DRONABINOL | CNR2, CNR1, GPR18 | CNR2 1/4885CNR1 2/4885MEN1 3300/4885 |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | SLC25A20, CPT2, NDUFAB1 | CNR2 91/4885CNR1 106/4885MEN1 2449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.